Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Carboxyamidotriazole Orotate by Tactical Therapeutics for Glioblastoma Multiforme (GBM): Likelihood of Approval
Carboxyamidotriazole Orotate is under clinical development by Tactical Therapeutics and currently in Phase II for Glioblastoma Multiforme (GBM). According to...